[Prognostic and therapeutic assessment of ovarian cancer on the basis of the enzyme status].
D000135:Acid Phosphatase / Q000378:metabolism; D000328:Adult; D000410:Alanine Transaminase / Q000378:metabolism; D000429:Alcohol Oxidoreductases / Q000378:metabolism*; D000469:Alkaline Phosphatase / Q000378:metabolism; D001219:Aspartate Aminotransferases / Q000378:metabolism; D002802:Cholinesterases / Q000378:metabolism*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D005956:Glucose-6-Phosphate Isomerase / Q000378:metabolism*; D005969:Glutamate Dehydrogenase / Q000378:metabolism; D006801:Humans; D006884:Hydroxybutyrate Dehydrogenase / Q000378:metabolism; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D007931:Leucyl Aminopeptidase / Q000378:metabolism*; D008049:Lipase / Q000378:metabolism*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000201:enzymology*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D011379:Prognosis; D000637:Transaminases / Q000378:metabolism*; D014361:Trypsin Inhibitors
D014361:Trypsin Inhibitors; D003520:Cyclophosphamide; D000429:Alcohol Oxidoreductases; D007770:L-Lactate Dehydrogenase; D006884:Hydroxybutyrate Dehydrogenase; D005969:Glutamate Dehydrogenase; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D008049:Lipase; D002802:Cholinesterases; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D010744:Phosphoric Monoester Hydrolases; D007931:Leucyl Aminopeptidase; D005956:Glucose-6-Phosphate Isomerase
Die prognostische und therapeutische Beurteilung des Ovarialcarcinoms anhand des Enzymstatus.